跳到主要內容

Sachs Adam David 的 Form 4/A 修正申報

修正

Vicarious Surgical Inc.(RBOT),2022/11/30 申報

申報編號
0001213900-22-076481
申報時間
2022/11/30
交易日
2022/11/28
申報延遲
2 天
10b5-1 計畫
表單沒有這欄(2023 年以前)
原始申報日
2022/11/30

這份申報列了 1 筆衍生性交易。沿用原件裡沒有重述的 3 筆交易。公開市場賣出合計 $6.76 萬。交易後 2 天申報。

這份修正申報重述了 0001213900-22-076205(2022/11/30 申報)的一部分,沒有重述的交易仍然有效,列在下面。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Sachs Adam DavidCIK 0001885593董事、高階主管(總裁、執行長)、持股 10% 以上大股東

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

這份申報沒有這一類的交易。

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2022/11/28Class A Common StockC轉換處分−11,329$0.00$011,239,063直接

沿用原件的交易

這份修正申報只重述了原件的一部分。原件其他的交易仍然有效,網站的交易表把它們算在這份修正申報底下。

來自 0001213900-22-076205(2022/11/30 申報)。

非衍生性證券(表 I)

沿用 0001213900-22-076205 的非衍生性證券交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2022/11/28Class A Common StockC轉換取得+11,329–F1–1,254,121直接
2022/11/28Class A Common StockS賣出處分−11,329$3.43F3−$38,858.471,242,792直接
2022/11/28Class A Common StockS賣出處分−8,325$3.45F5−$28,721.251,234,467直接

原件的附註

這幾筆交易的價格在原件上引用的附註。

F1

Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

表 I 有 1 筆交易的價格引用這則附註。

F3

This figure is the weighted average sales price of multiple trades ranging from $3.37 to $3.48 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

表 I 有 1 筆交易的價格引用這則附註。

F5

This figure is the weighted average sales price of multiple trades ranging from $3.36 to $3.62 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

表 I 有 1 筆交易的價格引用這則附註。

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F1

Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

F2

On November 30, 2022, the reporting person filed a Form 4 that mistakenly indicated an incorrect transaction date for the conversion of Class B Common Stock. The correct transaction date is 11/28/2022.

看 SEC EDGAR 上的完整原文 (在新分頁開啟)